Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 5 |
2024 | 3 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Long-term prognostic factors for PRRT in neuroendocrine tumors.
Front Med (Lausanne). 2023 Jun 9;10:1169970. doi: 10.3389/fmed.2023.1169970. eCollection 2023.
Front Med (Lausanne). 2023.
PMID: 37359009
Free PMC article.
First-in-Humans PET/MRI of In Vivo GD2 Expression in Osteosarcoma.
Trautwein NF, Reischl G, Seitz C, Dittmann H, Seith F, Scheuermann S, Feuchtinger T, Dombrowski F, Handgretinger R, Fuchs J, Pichler B, Fougère C, Schwenck J.
Trautwein NF, et al.
J Nucl Med. 2023 Feb;64(2):337-338. doi: 10.2967/jnumed.122.264626. Epub 2022 Sep 15.
J Nucl Med. 2023.
PMID: 36109181
Free PMC article.
No abstract available.
Item in Clipboard
Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3.
Hinterleitner M, Pfeiffer R, Trautwein NF, Sipos B, Singer S, Nadalin S, Königsrainer A, Lauer UM, la Fougère C, Zender L, Hinterleitner C.
Hinterleitner M, et al. Among authors: trautwein nf.
Front Endocrinol (Lausanne). 2024 Jan 8;14:1285529. doi: 10.3389/fendo.2023.1285529. eCollection 2023.
Front Endocrinol (Lausanne). 2024.
PMID: 38260136
Free PMC article.
Item in Clipboard
A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [64Cu]Cu-NOTA-ch14.18/CHO.
Trautwein NF, Schwenck J, Seitz C, Seith F, Calderón E, von Beschwitz S, Singer S, Reischl G, Handgretinger R, Schäfer J, Lang P, Pichler BJ, Schulte JH, la Fougère C, Dittmann H.
Trautwein NF, et al.
Theranostics. 2024 Jan 20;14(3):1212-1223. doi: 10.7150/thno.92481. eCollection 2024.
Theranostics. 2024.
PMID: 38323317
Free PMC article.
Item in Clipboard
Image Quality and Quantitative PET Parameters of Low-Dose [18F]FDG PET in a Long Axial Field-of-View PET/CT Scanner.
Calderón E, Schmidt FP, Lan W, Castaneda-Vega S, Brendlin AS, Trautwein NF, Dittmann H, la Fougère C, Kiefer LS.
Calderón E, et al. Among authors: trautwein nf.
Diagnostics (Basel). 2023 Oct 18;13(20):3240. doi: 10.3390/diagnostics13203240.
Diagnostics (Basel). 2023.
PMID: 37892061
Free PMC article.
Item in Clipboard
Optimization of Y-90 Radioembolization Imaging for Post-Treatment Dosimetry on a Long Axial Field-of-View PET/CT Scanner.
Linder PM, Lan W, Trautwein NF, Brosch-Lenz J, von Beschwitz S, Kupferschläger J, Reischl G, Grözinger G, Dittmann H, la Fougère C, Schmidt FP.
Linder PM, et al. Among authors: trautwein nf.
Diagnostics (Basel). 2023 Nov 9;13(22):3418. doi: 10.3390/diagnostics13223418.
Diagnostics (Basel). 2023.
PMID: 37998554
Free PMC article.
Item in Clipboard
Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies: Preliminary Evidence From a Clinical Pilot Study.
Trautwein NF, Hinterleitner C, Kiefer LS, Singer S, Mattern S, Schwenck J, Reischl G, Sipos B, Lauer UM, Dittmann H, Zender L, la Fougère C, Hinterleitner M.
Trautwein NF, et al.
Clin Nucl Med. 2024 Mar 1;49(3):207-214. doi: 10.1097/RLU.0000000000005006. Epub 2024 Jan 23.
Clin Nucl Med. 2024.
PMID: 38271237
Item in Clipboard
Cite
Cite